BioIgnite is an integrated metabolic-activation formula that combines a thermogenic amino acid, a neurostimulant alkaloid, an inflammation-modulating kinase inhibitor, and a selective β₂-adrenergic agonist. Together they are designed to:
- Enhance thermogenesis & fat oxidation by promoting AMPK activation (L-Theanine) [1][2][3], mobilizing free fatty acids (Caffeine) [10][11][12], and driving brown adipose tissue activation (Albuterol) [6][7].
- Improve glucose disposal & insulin sensitivity through adipose browning (L-Theanine) [1][2][3], inflammatory kinase inhibition (Amlexanox) [4][5], and muscle glucose uptake (Albuterol) [6][7].
- Reduce metabolic inflammation by targeting IKK-ε/TBK1 signaling with Amlexanox, restoring catecholamine responsiveness in adipocytes [4][5].
- Amplify mitochondrial energy metabolism via increased fatty acid oxidation (Caffeine, L-Theanine) [2][10], and β₂-adrenergic stimulation of oxidative tissues (Albuterol) [6][7].
These complementary mechanisms make BioIgnite a promising research candidate for studies of obesity, type 2 diabetes, fatty liver disease, and metabolic syndrome.
BioIgnite Structure
| Ingredient | Dose per Capsule | Key Actions |
| L-Theanine | 150 mg | AMPK activation; induces browning of white adipose tissue, improves glucose tolerance & insulin sensitivity [1][2][3] |
| Caffeine | 50 mg | Adenosine receptor antagonist; increases cAMP, lipolysis, fat oxidation, and resting energy expenditure [10][11][12] |
| Amlexanox | 50 mg | IKK-ε/TBK1 inhibition; reduces inflammation, restores adrenergic responsiveness, improves glycemia & fatty liver [4][5] |
| Albuterol | 3 mg | Selective β₂-agonist; activates human brown adipose tissue, increases energy expenditure & fat oxidation [6][7] |
Research Areas
- Thermogenesis & Fat Oxidation
- Glucose Disposal & Insulin Sensitivity
- Anti-inflammatory Metabolic Support
Mitochondrial & Energy Metabolism
